Intego Clinical recently attended PHUSE EU Connect 2023, which took place on November 5-8 in Birmingham, UK. This event was an essential milestone for our team, as it allowed us to engage with fellow healthcare and data science experts, exchange innovative ideas, and gain new insights.
Intego Clinical experts’ presentations sparked conversations and resonated with attendees, leading to profound and practical discussions. Here’s a glimpse of the topics and speakers from our team:
● Monika Ludwińska presented “Mr. (R)ight – Why R Should Be Used for Validating TFLs in Clinical Trials”
● Illia Skliar delivered a presentation “Boosting SAS Programming Efficiency with ChatGPT: A Clinical Trials Perspective.”
● Anna Amosova and Yuliia Cherednichenko collaborated on a presentation titled “Efficacy Endpoints in Adjuvant and Neoadjuvant Oncology Trials.”
The spirit of the event was best summed up by Edwin van Stein, Connect 2023 Chair: “Everywhere I looked, I saw people collaborating, innovating, and drawing inspiration from each other.” This reflects our own experience – working together contributes to progress in our field.
This year, Birmingham’s International Convention Centre (ICC) provided a perfect setting for various event activities, including workshops, presentations, and networking sessions. The smooth operation and the staff’s support ensured an enriching experience for everyone involved.
We’d also like to thank the organizers, speakers, and all the attendees who made PHUSE EU Connect 2023 a memorable event. The insights and connections we’ve gained are invaluable and will further fuel our initiatives as we continue to innovate in clinical data and biostatistics.
As we look to the future, we’re excited about participating in upcoming events like PHUSE US Connect 2024 in Bethesda, MD, and PHUSE EU Connect 2024 in Strasbourg, France, eager for more opportunities to learn, share, and grow.